MIAMI - eTradeWire -- GlucoPredict™ Advances AI Technology to Estimate Post-Meal Glucose Peaks Before Eating

Patent-pending platform combines AI-powered meal analysis, glucose-response modeling, and portion comparisons to support informed diabetes management.

PEMBROKE PINES, FL — November 4, 2026 — Metaboliq, Inc. is preparing the second pilot of GlucoPredict™, an AI-powered nutrition education platform designed to help individuals explore how food choices and portion sizes may influence blood glucose before eating.

The platform uses nutritional analysis and available glucose information to generate estimated post-meal glucose peaks, allowing users to explore potential glucose responses and compare portions before making food choices.

AI-Powered Meal Analysis and Glucose-Peak Estimates

GlucoPredict™ uses AI-assisted food recognition to identify meal components and estimate carbohydrates, proteins, fats, and other nutritional information. Its computational model generates an educational glucose-response curve, including an estimated peak after eating.

More on eTradeWire News

• Exclusively Cabinets Opens New Showroom In St. Clair Shores
• Milwaukee Welcomes The Great Junk Hunt – The Traveling Vintage Market Arrives This Weekend!
• AI Trading Agents Track Aerospace and Defense US Stocks Amid Rising Technology Investment (SATS, GILT, TSAT, IREN, JOBY, LUNR)
• SEO title: Surrogacy in Canada: November 6–8 Retreat | Sacred Surrogacy
• Houston Retail | Market Report 2026 Q3

Users can photograph meals, compare original and adjusted portions, and explore potential changes in estimated glucose responses. Meal history, visual comparisons, and personalized PDF reports help users understand their food choices and electronically share information with healthcare providers, supporting informed discussions and collaborative diabetes management.

Culturally Inclusive Nutrition Technology

Recognizing the connection between food, culture, and family traditions, GlucoPredict™ supports the analysis of Caribbean, Latin American, Mediterranean, African, Asian, and other cuisines.

Available in English, Spanish, French, and Haitian Creole, the platform extends nutrition education to multilingual communities.

Innovation Inspired by Experience

GlucoPredict™ was founded by Anna Laudun Beauboeuf, a specialist in psycho-pedagogy with more than 20 years of experience in healthcare, diabetes patient education, and medical practice operations.

Living with type 1 diabetes since childhood, Beauboeuf developed the concept through personal experience and professional work with individuals managing diabetes.

"Living with type 1 diabetes since childhood, I know how overwhelming it can be to manage a condition that never takes a day off. Between insulin adjustments, unexpected highs and lows, and the misconceptions of others, there are moments when you feel lost, misunderstood, or even excluded from the simple joys others take for granted," said Beauboeuf. "I created GlucoPredict™ to ease a small part of that burden, helping people feel more informed and confident while enjoying food, family gatherings, and the traditions that bring us together."

More on eTradeWire News

• Feldmeyer' Financial Group's Alyssa Miller Joins Dayton Children's Hospital Committee (PGAC)
• Baltzer Marketing Launches Headwater CRM to Help Law Firms Connect Marketing to Signed Cases
• Discovery Energy Outlook Finds U.S. LNG Exports Are Tying American Natural Gas Costs to Global Markets
• Daughter of NBA Legend Dominique Wilkins, Ayisha Wilkins,Breaks Her Silence in Revealing New Memoir
• History Matters - The Election of 1800

Preparing for the Second Pilot

Following its initial pilot, GlucoPredict™ is preparing a second evaluation phase focused on meal-analysis performance, glucose-response estimates, portion comparisons, multilingual accessibility, and user experience.

Feedback from participants and healthcare professionals will guide further development. The underlying technology is the subject of a pending patent application.

About Metaboliq, Inc.

Metaboliq, Inc. develops digital health solutions focused on accessible, practical, and culturally inclusive nutrition education.

GlucoPredict™ provides educational glucose-response estimates, not direct measurements or clinically validated predictions of individual outcomes. It does not provide insulin dosing recommendations, support medical diagnosis or treatment decisions, or replace professional medical advice.

Website: https://www.glucopredict.com